A burgeoning and little-regulated private industry that specially mixes drugs at so-called compounding pharmacies poses a public-health hazard that the Trump administration is about to make a whole lot worse.
A bipartisan bill that promises more money for research and development is actually full of giveaways for the pharmaceutical industry and other trade groups.
Two outside-the-box suggestions to take the party in a more progressive direction.
You need to be logged in to comment.(If there's one thing we know about comment trolls, it's that they're lazy)
Robert Kuttner is co-founder and co-editor of The American Prospect, and professor at Brandeis University's Heller School. His latest book is Debtors' Prison: The Politics of Austerity Versus Possibility. He writes columns for The Huffington Post, The Boston Globe and the New York Times international edition.